A judge in the U.S. Court of Appeals blocked HHS from implementing a rule requiring drug companies to put the manufacturer’s list price for prescription drugs or biological products to wholesalers or direct purchasers in TV commercials.
The decision Tuesday by U.S. District Judge Patricia A. Millett was the latest setback for President Donald J. Trump and his administration’s ongoing effort to lower drug prices.
In rendering her opinion, Millett wrote that HHS “acted unreasonably” in assuming it could tie the rule to Medicare or Medicaid programs. She added that “although
Uncategorized